Opinion: Digital endpoints library can aid clinical trials for new medicines

At nearly every major industry conference — from HLTH to CNS Summit, Exponential Medicine, and Rock Health Summit — speakers are talking about the benefits of decentralized clinical trials and digital endpoints. We are quite excited about the latter.

For a new drug to be approved, the manufacturer must provide the FDA with substantial evidence that it has a clinically meaningful effect on patients. It does this by providing data on endpoints, like survival or a substantial reduction in a biomarker like LDL cholesterol or hemoglobin A1c.

Read the rest…

Read Original Article: Opinion: Digital endpoints library can aid clinical trials for new medicines »